Suchergebnisse

The use of enzymes for industrial functions needs enzymes that are stable, selective and might be used repeatedly. The aim of the study was to determine the chitinase enzyme's function, selectivity, and stability in amobil chitosan membranes. The research method consisted of stages: production of the chitinase enzyme which included the manufacture of chitin colloidal substrate, rejuvenation of thermophilic bacteria, preparation of the inoculum and determining the optimum time of production, fractionation of ammonium sulfate, chitinase enzyme immobilization technique and activity, stability and selectivity test of amobil enzyme. The results demonstrated that chitinase activity, which incorporates the optimum temperature and thus the optimum concentration of production within the immobilization technique, had an optimum temperature of 65oC on day 4 of production time with an OD value of 0.9876. The selectivity of amobil chitinase with metal ions Cd (II), Pb (II), Zn (II), and Hg (II) demonstrated that amobil chitinase was selective for these ions. Eamobil chitinase was heat stable at 55-75oC and resistant to organic solvents, suggesting that it could be used repeatedly.

Background: Since the emergence of COVID-19 there have been increasing global concerns about delays and/or discontinuations in cancer care. However, it is unclear to what extent systemic cancer therapy was impacted by COVID-19 in countries with relatively low COVID-19 infection rates. We examined changes in systemic cancer therapy in Australia during the COVID-19 pandemic. Methods: We conducted a national observational study using de-identified records of government-subsidised cancer medicines dispensed to a random 10% sample of Australians between January 2017 to December 2020. We reported monthly dispensing and initiation rates of antineoplastic (chemo-, immuno- and targeted therapy), endocrine and supportive medicines per 100,000 population. We reported monthly discontinuation rates (defined as ≥90 days gap between cancer medicine dispensings) per 1,000 people treated. We used interrupted time series analysis to examine changes during times of increased COVID-19 risk and related public health measures (March, April and July 2020). Findings: Between January 2017 and December 2020, 1,011,255 cancer medicines were dispensed to 51,515 people. Overall, there were no reductions in antineoplastic dispensing or initiation during the COVID-19 pandemic. In March 2020, we observed a temporary increase of 39/100,000 (95% CI: 14 to 65/100,000) in antineoplastic dispensing, driven by immunotherapy and targeted therapy. In April 2020, we observed a temporary decrease in chemotherapy initiation (-2/100,000, 95% CI: -4 to -1/100,000) and temporary increase in discontinuation of all antineoplastic medicines (35/1,000, 95% CI: 20 to 51/1,000), but these changes were not sustained. Interpretation: The effective control of COVID-19 in Australia appears to have mitigated the initial impact of COVID-19 on systemic cancer therapy. We observed only small and temporary changes in the use of some cancer medicines early in the pandemic. Funding: National Health and Medical Research Council; National Breast Cancer Foundation; Translational Cancer Research Network, supported by the Cancer Institute NSW.

Abstract. Minasa Baji Village has potential that needs to be developed, among others, there is a Glass Tea Factory that produces a large amount of tea waste every day and cow dung waste. Cow dung waste located in the cattle farms and farmer community who manage it into bokashi fertilizer but it has not developed rapidly and has not yet produced income that can bring prosperity to the farmer community processing it. This is due to the fact that bokashi fertilizers production are still limited, resources are inadequate, the business capital is minimal and the management system is not yet professional. Therefore, Pengembangan Desa Mitra Program(PDMP) will be implemented in Minasa Baji Village, Bantimurung District, Maros Regency that aims to increase farmer community empowerment in processing tea waste and cow dung waste. They should be in good quality production and competitive in the market so that it can improve farmar community welfare. Another word, it is expected to be able to increase knowledge for partners on management procedures for managing a business, such as in terms of marketing, financial management, bookkeeping systems, optimizing the institutional functions of existing farmer community, assisting local governments to reduce unemployment and regional income.To that end, farmer community empowerment in Minasa Baji Village is required in processing the potential of local raw material resources to make a quality and competitive fertilizer product in the market continuously

Objectives: Older adults constitute the majority of patients with lung cancer. However, they are under-represented in clinical trials as eligibility criteria often restrict enrolment based on comorbidities that are common with aging. We aimed to describe comorbidities relating to trial exclusion criteria in older adults with lung cancer, determine the proportion that would typically be excluded from trials, and examine the impact on treatment uptake. Materials and Methods: We conducted a population-based study of people aged ≥65 years diagnosed with metastatic lung cancer using linked data for clients of the Australian Government Department of Veterans' Affairs (2005–2015). We defined trial-typical patients based on the absence of comorbidities related to the following: inadequate organ (cardiac, renal, hepatic, marrow) function; cognitive dysfunction; poor performance status (PS); prior malignancy within 5 years. We report systemic therapy uptake within 3 months of diagnosis. Results: Our study included 677 patients (median age 84). Over half (53.4%) were not trial-typical, with the most common reasons being poor PS (37.5%), cardiac disease (19.2%), and prior cancer (12.9%). Eighty-two (12.1%) received systemic therapy. Patients with poor PS, cardiac disease, and dementia had lower treatment uptake rates. However, there was no significant difference in treatment uptake between trial-typical and non-trial-typical patients (13.4 vs 11.0%). Conclusion: More than half of older adults with advanced lung cancer would be typically excluded from trial participation. Future clinical trials of older adults need to consider broader eligibility criteria to better reflect this population to gain the best evidence for their care.

The research leading to these results has received funding from the European Union's Seventh Framework Programme under grant agreement FP7 ICT 2011 – 284553 (Acronym: Si-CODE), the NEUROSCAFFOLDS Project n. 604263, the National Natural Science Foundation of China (Grant number: 51361130033) and the Ministry of Science and Technology of China (973 Grant number: 2014CB965003).

Solar powered electrochemical production of hydrogen through water electrolysis is an active and important research endeavor. However, technologies and roadmaps for implementation of this process do not exist. In this perspective paper, we describe potential pathways for solar hydrogen technologies into the marketplace in the form of photoelectrochemical or photovoltaic driven electrolysis devices and systems. We detail technical approaches for device and system architectures, economic drivers, societal perceptions, political impacts, technological challenges, and research opportunities. Implementation scenarios are broken down into short term and long term markets, and a specific technology roadmap is defined. In the short term, the only plausible economical option will be photovoltaic driven electrolysis systems for niche applications. In the long term, electrochemical solar hydrogen technologies could be deployed more broadly in energy markets but will require advances in the technology, significant cost reductions, and or policy changes. Ultimately, a transition to a society that significantly relies on solarhydrogen technologies will benefit from continued creativity and influence from the scientific community